Could existing melanoma drugs work for other rare cancers? new trial aims to find out.
Disease control
Not yet recruiting
This trial tests if a combination of two drugs (dabrafenib and trametinib) can shrink or control rare cancers that have a specific gene change called BRAF V600. These drugs are already approved for melanoma and lung cancer with this mutation. About 30 adults and children with var…
Phase: PHASE2, PHASE3 • Sponsor: Cancer Research UK • Aim: Disease control
Last updated Apr 28, 2026 23:50 UTC